Angiex Inc. is a privately held biotech startup whose mission is to exploit newly discovered biological transport mechanisms to make drugs with revolutionary power over cancer. Based in Cambridge, Mass., Angiex was founded by a scientific team of leading experts in angiogenesis, vascular biology, and oncology. The company is developing a novel portfolio of Nuclear-Delivered Antibody-Drug Conjugates™ (ND-ADCs) that release therapeutic payloads directly into the nucleus or cytosol, where the site of payload action is located.
View Top Employees from Angiex Inc.| Website | https://angiex.com |
| Revenue | $6 million |
| Funding | $2.9 million |
| Employees | 11 (7 on RocketReach) |
| Founded | 2015 |
| Address | 610 Main Street, Cambridge, Massachusetts 02139, US |
| Phone | (617) 576-1753 |
| Industry | Biotechnology Research, Business Services General, Health Care, Business Services, Therapeutics |
| SIC | SIC Code 873 Companies, SIC Code 87 Companies |
| NAICS | NAICS Code 54 Companies, NAICS Code 54171 Companies, NAICS Code 541714 Companies, NAICS Code 541 Companies, NAICS Code 5417 Companies |
Looking for a particular Angiex Inc. employee's phone or email?
Angiex Inc. Questions
The Angiex Inc. annual revenue was $6 million in 2024.
Marty Duvall is the Chief Executive Officer and BOD Member of Angiex Inc..
7 people are employed at Angiex Inc..
Angiex Inc. is based in Cambridge, Massachusetts.
The NAICS codes for Angiex Inc. are [54, 54171, 541714, 541, 5417].
The SIC codes for Angiex Inc. are [873, 87].
Top Angiex Inc. Employees
-
55+
-
31
-
View
Aaron Mallek
Scientist- Bioconjugation and Bioanalytics at Angiex Inc.
Boston, Massachusetts, United States23 -
12
Related Companies
